REGN
Regeneron Pharmaceuticals Inc.
Latest News for REGN
Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them this month. These decisio......
In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron, with a price target of $725.00. The company’s sha......
Insiders have been trading these 5 stocks: (($BX)), (($REGN)), (($SCHW)), (($TSE:CLS)) and (($GLW)). Here is a breakdown of their recent trades and......
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is spearheading a pivotal Phase ......
In a report released yesterday, Cory Kasimov from Evercore ISI maintained a Buy rating on Regeneron, with a price target of $750.00. The company’s ......
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals recently complet......
Jefferies analyst Akash Tewari maintained a Buy rating on Regeneron today and set a price target of $870.00. The company’s shares opened today at $......
In a report released today, William Pickering from Bernstein maintained a Buy rating on Regeneron, with a price target of $781.00. The company’s sh......
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a critical study t......
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is initiating a new clinical stu......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $755.90 | +2.6% | 1.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW